基于自动化MR的肺容积分割在人群全身MR成像中的应用:与临床特征、肺功能检测和阻塞性肺疾病的相关性
在KORA-FF4人群研究的400名受试者中,利用全身MRI的冠状位T1-DIXON-VIBE序列自动分割获得肺容积,其与年龄、男性、当前吸烟和身高正相关,与RV和FEV1/FVC独立相关,对阻塞性肺疾病识别AUC为0.673-0.654。
要点
- 全身MRI非专用序列可自动分割肺容积,约为预测TLC的65%和FRC的125%。
- MRI肺容积与RV、FEV1/FVC独立相关,联合可解释32%的变异。
- 身高指数化MRI肺容积识别阻塞性肺疾病AUC为0.673-0.654,仅中等准确度。
核心结论
- 非专用全身MRI获得的肺容积与RV和FEV1/FVC独立相关,对阻塞性肺疾病识别具有中等准确度,可能成为无PFT时评估肺部健康的工具。
研究设计与样本
- 基于人群的KORA-FF4队列研究,400名受试者(56.4±9.2岁,57.6%男性)行全身MRI包括冠状位T1-DIXON-VIBE吸气屏气序列,基于自动框架导出肺容积,与常见预测因素、肺功能检测(肺量计和肺气体交换,n=214)及阻塞性肺疾病进行相关分析。
诊断标准与关键数值
- MRI肺容积为4.0±1.1 L,为预测TLC的64.8±14.9%和FRC的124.4±27.9%;与TLC、肺泡容积和RV相关性最佳(r均为0.57),与FEV1/FVC负相关(r=0.36),与一氧化碳转移因子负相关(r=0.16);RV和FEV1/FVC独立且增量相关(β=0.50,p=0.04和β=-0.02,p=0.02),解释32%的变异;身高指数化MRI肺容积识别阻塞性肺疾病AUC为0.673-0.654。
临床应用与阅片要点
- 作者认为,当肺功能检测不可用时,全身MRI自动导出的肺容积可能是有前景的评估肺部健康的工具。
局限性
- 对阻塞性肺疾病识别的准确度为中等(AUC 0.673-0.654)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Whole-body MR imaging is increasingly utilised; although for lung dedicated sequences are often not included, the chest is typically imaged. Our objective was to determine the clinical utility of lung volumes derived from non-dedicated MRI sequences in the population-based KORA-FF4 cohort study.
METHODS: 400 subjects (56.4 ± 9.2 years, 57.6% males) underwent whole-body MRI including a coronal T1-DIXON-VIBE sequence in inspiration breath-hold, originally acquired for fat quantification. Based on MRI, lung volumes were derived using an automated framework and related to common predictors, pulmonary function tests (PFT; spirometry and pulmonary gas exchange, n = 214) and obstructive lung disease.
RESULTS: MRI-based lung volume was 4.0 ± 1.1 L, which was 64.8 ± 14.9% of predicted total lung capacity (TLC) and 124.4 ± 27.9% of functional residual capacity. In multivariate analysis, it was positively associated with age, male, current smoking and height. Among PFT indices, MRI-based lung volume correlated best with TLC, alveolar volume and residual volume (RV; r = 0.57 each), while it was negatively correlated to FEV1/FVC (r = 0.36) and transfer factor for carbon monoxide (r = 0.16). Combining the strongest PFT parameters, RV and FEV1/FVC remained independently and incrementally associated with MRI-based lung volume (β = 0.50, p = 0.04 and β = - 0.02, p = 0.02, respectively) explaining 32% of the variability. For the identification of subjects with obstructive lung disease, height-indexed MRI-based lung volume yielded an AUC of 0.673-0.654.
CONCLUSION: Lung volume derived from non-dedicated whole-body MRI is independently associated with RV and FEV1/FVC. Furthermore, its moderate accuracy for obstructive lung disease indicates that it may be a promising tool to assess pulmonary health in whole-body imaging when PFT is not available.
KEY POINTS: • Although whole-body MRI often does not include dedicated lung sequences, lung volume can be automatically derived using dedicated segmentation algorithms • Lung volume derived from whole-body MRI correlates with typical predictors and risk factors of respiratory function including smoking and represents about 65% of total lung capacity and 125% of the functional residual capacity • Lung volume derived from whole-body MRI is independently associated with residual volume and the ratio of forced expiratory volume in 1 s to forced vital capacity and may allow detection of obstructive lung disease.
引用
- Mueller J, Karrasch S, Lorbeer R, et al. Automated MR-based lung volume segmentation in population-based whole-body MR imaging: correlation with clinical characteristics, pulmonary function testing and obstructive lung disease. Eur Radiol. 2018. PMID: 30151641. doi:10.1007/s00330-018-5659-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。